Journal of Hematology and Oncology Research

Hehuang Xie, Virginia Bioinformatics Institute
Editorial Board

Hehuang Xie

Virginia Bioinformatics Institute · United States

Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601

Research interests

  • The Primary Research Interest Of Xie'S Group Is To Understand The Molecular Mechanisms Underlying Epigenetic Transitions During Important Biological Processes Associated With Human Complex Diseases.&Nbsp; Toward This Goal
  • My Group Emphasizes The Development Of High-Throughput Sequencing Approaches For Data Generation
  • The Implementation Of Computational Tools For -Omics Data Analysis.&Nbsp; In Particular
  • The Group Is Interested In Strategies To Monitor The Fidelity Of Dna Methylation Inheritance
  • Assess Methylation Variation Within
  • Between Cell Populations
  • Identify True Epimutations
  • And
  • Eventually
  • Discover Novel Therapies.&Nbsp; Our Previous Studies Include Bio-Technique Development To Facilitate Targeted Epigenome Sequencing
  • Cpg Islands
  • Alu Repeats In Particular
  • Model Establishment To Assess Dna Methylation Variations
  • Simulate Epigenetic State Transitions During Stem Cell Differentiation
  • Reprogramming
  • Disease Genesis.&Nbsp; We Have Successfully Applied Techniques
  • Bioinformatics Tools To Identify Diagnosis Markers For Diseases

Biography

  • Dr. Hehuang Xie graduated from the University of Iowa with Ph.D. in genetics and a master degree in computer science in 2003. 
  • After his graduate studies, Dr. Xie received his postdoctoral training in the field of bioinformatics at The University of Iowa and The University of Minnesota. 
  • In 2005, Dr. Xie joined the Cancer Biology and Epigenomics Program, Children Memorial Research Center; 
  • Department of Pediatrics, Northwestern University as a research faculty. 
  • Currently, Dr. Xie is an associate professor at the Virginia Bioinformatics Institute.

Considering JHOR for your work?

This journal is guided by Hehuang Xie (Virginia Bioinformatics Institute) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu